During the last session, Privia Health Group Inc. (NASDAQ:PRVA)’s traded shares were 1.0 million. At the end of the trading day, the stock’s price was $28.58, reflecting an intraday loss of -2.29% or -$0.67. The 52-week high for the PRVA share is $50.77, that puts it down -77.64 from that peak though still a striking 37.05% gain since the share price plummeted to a 52-week low of $17.99. The company’s market capitalization is $2.86B, and the average trade volume was 666.78K shares over the past three months.
Privia Health Group Inc. (PRVA) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 1.50. PRVA has a Sell rating from 0 analyst(s) out of 13 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 13 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be $0.01.
Privia Health Group Inc. (NASDAQ:PRVA) trade information
Privia Health Group Inc. (PRVA) registered a -2.29% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -2.29% in intraday trading to $28.58 this Wednesday, 06/22/22, hitting a weekly high. The stock’s 5-day price performance is 9.29%, and it has moved by 21.88% in 30 days. Based on these gigs, the overall price performance for the year is -38.54%.
The consensus price target of analysts on Wall Street is $34.33, which implies an increase of 16.75% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $29.00 and $40.00 respectively. As a result, PRVA is trading at a discount of -39.96% off the target high and -1.47% off the low.
Privia Health Group Inc. (PRVA) estimates and forecasts
Statistics show that Privia Health Group Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Privia Health Group Inc. (PRVA) shares have gone up 21.67% during the last six months, with a year-to-date growth rate less than the industry average at -138.89% against -3.00. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to grow 100.60% this quarter and then jump 122.20% in the quarter after that. In the rating firms’ projections, revenue will increase 27.80% compared to the previous financial year.
Revenue for the current quarter is expected to be $498.53 million as predicted by 12 analyst(s). Meanwhile, a consensus of 12 analyst(s) estimates revenue growth to $525.26 million by the end of Sep 2022.
While earnings are projected to return -701.50% in 2022.
Privia Health Group Inc. is due to release its next quarterly earnings on November 08. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Privia Health Group Inc. (NASDAQ:PRVA)’s Major holders
Privia Health Group Inc. insiders own 12.49% of total outstanding shares while institutional holders control 81.43%, with the float percentage being 93.05%. Goldman Sachs Group Inc is the largest shareholder of the company, while 200 institutions own stock in it. As of Dec 30, 2021, the company held over 28.01 million shares (or 25.89% of all shares), a total value of $724.55 million in shares.
The next largest institutional holding, with 4.14 million shares, is of Bank Of New York Mellon Corporation’s that is approximately 3.83% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $110.61 million.
Also, the Mutual Funds coming in first place with the largest holdings of Privia Health Group Inc. (PRVA) shares are Vanguard Total Stock Market Index Fund and Franklin Strategic Series-Franklin Small Cap Growth Fund. Data provided on Dec 30, 2021 indicates that Vanguard Total Stock Market Index Fund owns about 1.21 million shares. This amounts to just over 1.12 percent of the company’s overall shares, with a $31.26 million market value. The same data shows that the other fund manager holds slightly less at 1.17 million, or about 1.08% of the stock, which is worth about $24.91 million.